BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21162717)

  • 1. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
    Ridge AL; Bero LA; Hill SR
    BMC Health Serv Res; 2010 Dec; 10():340. PubMed ID: 21162717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.
    Oguntunde O; Charyeva Z; Cannon M; Sambisa W; Orobaton N; Kabo IA; Shoretire K; Danladi SE; Lawal N; Sadauki H
    BMC Pregnancy Childbirth; 2015 Jun; 15():130. PubMed ID: 26037906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
    Eddy KE; Vogel JP; Zahroh RI; Bohren MA
    BJOG; 2022 Feb; 129(3):379-391. PubMed ID: 34520111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of treatment for eclampsia in public health institutions in Maharashtra, India.
    Chaturvedi S; Randive B; Mistry N
    J Health Popul Nutr; 2013 Mar; 31(1):86-95. PubMed ID: 23617209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India.
    Katageri G; Charantimath U; Joshi A; Vidler M; Ramadurg U; Sharma S; Bannale S; Payne BA; Rakaraddi S; Karadiguddi C; Mungarwadi G; Kavi A; Sawchuck D; Derman R; Goudar S; Mallapur A; Bellad M; Magee LA; Qureshi R; von Dadelszen P;
    Reprod Health; 2018 Jun; 15(Suppl 1):91. PubMed ID: 29945665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals.
    Barua A; Mundle S; Bracken H; Easterling T; Winikoff B
    Int J Gynaecol Obstet; 2011 Dec; 115(3):231-4. PubMed ID: 21930268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia.
    Aaserud M; Lewin S; Innvaer S; Paulsen EJ; Dahlgren AT; Trommald M; Duley L; Zwarenstein M; Oxman AD
    BMC Health Serv Res; 2005 Nov; 5():68. PubMed ID: 16262902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey.
    Long Q; Oladapo OT; Leathersich S; Vogel JP; Carroli G; Lumbiganon P; Qureshi Z; Gülmezoglu AM;
    BJOG; 2017 Nov; 124(12):1883-1890. PubMed ID: 27885772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil.
    Lotufo FA; Parpinelli MA; Osis MJ; Surita FG; Costa ML; Cecatti JG
    BMC Pregnancy Childbirth; 2016 Aug; 16(1):254. PubMed ID: 27577571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of care in early detection and management of pre-eclampsia/eclampsia in health facilities in Afghanistan.
    Ansari N; Manalai P; Maruf F; Currie S; Stekelenburg J; van Roosmalen J; Kim YM; Tappis H
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):36. PubMed ID: 30658606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan.
    Kim YM; Ansari N; Kols A; Tappis H; Currie S; Zainullah P; Bailey P; van Roosmalen J; Stekelenburg J
    BMC Pregnancy Childbirth; 2013 Oct; 13():186. PubMed ID: 24119329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practice.
    Bigdeli M; Zafar S; Assad H; Ghaffar A
    PLoS One; 2013; 8(3):e59158. PubMed ID: 23555626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and fetal outcomes after introduction of magnesium sulphate for treatment of preeclampsia and eclampsia in selected secondary facilities: a low-cost intervention.
    Tukur J; Ahonsi B; Ishaku SM; Araoyinbo I; Okereke E; Babatunde AO
    Matern Child Health J; 2013 Sep; 17(7):1191-8. PubMed ID: 22956402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
    Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
    Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of facility readiness and provider preparedness for dealing with postpartum haemorrhage and pre-eclampsia/eclampsia in public and private health facilities of northern Karnataka, India: a cross-sectional study.
    Jayanna K; Mony P; B M R; Thomas A; Gaikwad A; H L M; Blanchard JF; Moses S; Avery L
    BMC Pregnancy Childbirth; 2014 Sep; 14():304. PubMed ID: 25189169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres.
    De Silva DA; Sawchuck D; von Dadelszen P; Basso M; Synnes AR; Liston RM; Magee LA
    J Obstet Gynaecol Can; 2015 Nov; 37(11):975-87. PubMed ID: 26629718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium sulphate in management of severe pre-eclampsia and eclampsia.
    Dhakal G; Subedi M; Paudel K
    J Nepal Health Res Counc; 2012 May; 10(21):113-7. PubMed ID: 23034372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.
    Gordon R; Magee LA; Payne B; Firoz T; Sawchuck D; Tu D; Vidler M; de Silva D; von Dadelszen P
    J Obstet Gynaecol Can; 2014 Feb; 36(2):154-163. PubMed ID: 24518915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MgSO4-therapy in pre-eclampsia/eclampsia. Review of the literature].
    Minkov R; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42 Suppl 2():24-7. PubMed ID: 14619751
    [No Abstract]   [Full Text] [Related]  

  • 20. Scale-up of magnesium sulfate for treatment of pre-eclampsia and eclampsia in Nigeria.
    Danmusa S; Coeytaux F; Potts J; Wells E
    Int J Gynaecol Obstet; 2016 Sep; 134(3):233-6. PubMed ID: 27394067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.